Semaglutide shows significant weight loss and health benefits in four-year obesity study

FHS
May 15, 2024
2:16 am

A study in Nature Medicine evaluated the effects of semaglutide on weight and anthropometric outcomes in adults with obesity but without diabetes, finding significant weight loss and improved health metrics over four years. The study also highlighted the safety and tolerability of semaglutide across different BMI categories.

New implant offers hope for nerve repair after spinal cord injury

A research team at RCSI University of Medicine and Health Sciences has developed a new implant that conveys electrical signals and may have the potential

August 28, 2024

Needle-free vaccine patch can protect people from deadly Zika virus

A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.

December 1, 2023

Is there an association between vitamin D deficiency and sepsis mortality?

The impact of deficient serum vitamin D levels on sepsis prognosis.

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.